Literature DB >> 17566704

Effect of dietary cholesterol and high fat on ceramide concentration in rat tissues.

Ikuyo Ichi1, Kayoko Nakahara, Kaori Kiso, Shosuke Kojo.   

Abstract

OBJECTIVE: Recent studies have indicated that plasma sphingomyelin levels and sphingomyelinase activity are risk factors for atherosclerosis. Therefore, it is suggested that ceramides, which are hydrolyzed products of sphingomyelin and a biologically active lipid causing apoptosis in a variety of cells, have an important role in the incidence of atherosclerosis. In this study, we examined whether cholesterol- and fat-enriched diets, which are causes of atherosclerosis, affect ceramide metabolism. In addition, we found a relation among lipid markers of atherosclerosis such as cholesterol, triacylglycerol, and ceramide concentrations.
METHODS: Male Wistar rats were fed a diet supplemented with 1% cholesterol or 30% high-fat diet for 8 wk. Tissue ceramide levels were analyzed using electrospray tandem mass spectrometry.
RESULTS: The major ceramides in plasma and the liver were C24:0 and C24:1. The major ceramides in adipose tissues were C16:0 and C24:0. Therefore, the ceramide composition of the adipose tissues was different from that of plasma and the liver. In addition, total ceramide levels in plasma and the adipose tissues of rats fed cholesterol were higher than those in the control group.
CONCLUSION: The accumulation of cholesterol caused an increase in ceramides, which might be a new risk factor for atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566704     DOI: 10.1016/j.nut.2007.04.014

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  15 in total

1.  Quantitation of multiple sphingolipid classes using normal and reversed-phase LC-ESI-MS/MS: comparative profiling of two cell lines.

Authors:  M Athar Masood; Raghavendra P Rao; Jairaj K Acharya; Josip Blonder; Timothy D Veenstra
Journal:  Lipids       Date:  2011-11-29       Impact factor: 1.880

2.  Mass spectrometry imaging of rat brain lipid profile changes over time following traumatic brain injury.

Authors:  Aurelie Roux; Ludovic Muller; Shelley N Jackson; Jeremy Post; Katherine Baldwin; Barry Hoffer; Carey D Balaban; Damon Barbacci; J Albert Schultz; Shawn Gouty; Brian M Cox; Amina S Woods
Journal:  J Neurosci Methods       Date:  2016-02-10       Impact factor: 2.390

3.  High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei.

Authors:  Grzegorz Chocian; Adrian Chabowski; Małgorzata Zendzian-Piotrowska; Ewa Harasim; Bartłomiej Łukaszuk; Jan Górski
Journal:  Mol Cell Biochem       Date:  2010-02-20       Impact factor: 3.396

4.  Mechanisms and clinical implications of hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Gregory J Gores
Journal:  Clin Lipidol       Date:  2010-02-01

5.  Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Yu Yang; Arthur J McCullough; Susan Marczewski; Carole Bennett; Satish C Kalhan
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-05       Impact factor: 2.566

6.  Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease.

Authors:  Jing Hua; Xiong Ma; Tonya Webb; James J Potter; Mathias Oelke; Zhiping Li
Journal:  J Lipid Res       Date:  2010-02-24       Impact factor: 5.922

7.  Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide.

Authors:  J J Dubé; F Amati; F G S Toledo; M Stefanovic-Racic; A Rossi; P Coen; B H Goodpaster
Journal:  Diabetologia       Date:  2011-02-17       Impact factor: 10.122

8.  Blood sphingolipidomics in healthy humans: impact of sample collection methodology.

Authors:  Samar M Hammad; Jason S Pierce; Farzan Soodavar; Kent J Smith; Mohammed M Al Gadban; Barbara Rembiesa; Richard L Klein; Yusuf A Hannun; Jacek Bielawski; Alicja Bielawska
Journal:  J Lipid Res       Date:  2010-07-21       Impact factor: 5.922

9.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

Review 10.  Ceramide: a common pathway for atherosclerosis?

Authors:  Jean Bismuth; Peter Lin; Qizhi Yao; Changyi Chen
Journal:  Atherosclerosis       Date:  2007-10-25       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.